A Recombinant Chimeric Protein Specifically Induces Mutant KRAS Degradation and Potently Inhibits Pancreatic Tumor Growth
Oncotarget- United States
doi 10.18632/oncotarget.9996
Full Text
Abstract
Available in
Categories
Date
June 14, 2016
Authors
Publisher
Impact Journals, LLC